Climate Change Data

Apellis Pharmaceuticals, Inc.

Climate Impact & Sustainability Data (2021)

Reporting Period: 2021

Environmental Metrics

Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:6030 lbs biological waste, 170 lbs hazardous waste, 80 lbs non-hazardous waste
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Patients & Access to Medicine
  • Diversity, Equity, and Inclusion (DEI)
  • Quality and Safety
  • Environment
  • Integrity and Ethics

Environmental Achievements

  • Removed all single-use plastics in offices pre-pandemic; implemented plant-based, biodegradable alternatives during pandemic; saved nearly 125,000 plastic bottles by June 2022 through filtered water dispensers; 6,030 lbs of biological waste treated safely; all 170 lbs of hazardous waste treated properly by a third-party vendor

Social Achievements

  • Launched ApellisAssist™, a patient support program ensuring access to medication regardless of ability to pay; created a diversity, equity, and inclusion (DEI) program; launched Project Apollo, an updated quality management system focused on compliance, product quality, innovation, and patient safety; introduced a new corporate goal to measure employee engagement; conducted a company-wide annual employee engagement survey; implemented actions to improve employee experience including work prioritization, resource allocation, employee wellness, and enhancements to employee benefits; employee attrition significantly below market average; created a Leadership Development Program

Governance Achievements

  • Established an independent whistleblower hotline; implemented a robust business ethics program and formalized Anti-Bribery and Anti-Corruption policy; developed a Supplier Code of Conduct; launched Project Apollo to optimize team performance and drive compliance

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Not disclosed
Short-term Goals:
  • Not disclosed

Environmental Challenges

  • Potential for business disruption from extreme weather and natural disasters; potential future carbon disclosure and compliance requirements; reputational risks from not proactively addressing climate change issues
Mitigation Strategies
  • Regular assessment of potential climate change impacts; monitoring industry information on evolving risks and environmental concerns; risk management discussions among leadership team; review of carbon emissions disclosure

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement
  • Supplier Code of Conduct

Climate-Related Risks & Opportunities

Physical Risks
  • Extreme weather, natural disasters
Transition Risks
  • Regulatory changes (carbon disclosure, compliance), reputational risks
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: SASB Biotechnology & Pharmaceuticals Standard, TCFD

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

  • Not disclosed

Not disclosed

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • Not disclosed